Access cutting-edge parkinson's disease treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access parkinson's disease specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related parkinson's disease treatment provided free
A study to determine if BHV-8000 is efficacious, safe and tolerable in adults diagnosed with early Parkinson's disease.
Sponsor: Biohaven Therapeutics Ltd.
Check if you qualify for this parkinson's disease clinical trial in Chicago, IL
If you're searching for parkinson's disease treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced parkinson's disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.